Statera Biopharma Inc
(STAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 236 | 283 | 392 | 228 | 870 |
| Gross Profit | 236 | 283 | 392 | 228 | 870 |
| Operating Expenses | 864 | 1,551 | 1,460 | 2,064 | 2,084 |
| Operating Income | -628 | -1,268 | -1,068 | -1,836 | -1,214 |
| Other Income | 180 | 139 | 196 | 578 | 15 |
| Pre-tax Income | -448 | -1,128 | -873 | -1,259 | -1,198 |
| Net Income Continuous | -448 | -1,128 | -873 | -1,259 | -1,198 |
| Minority Interests | -16 | -24 | -22 | -34 | -29 |
| Net Income | $-432 | $-1,104 | $-851 | $-1,225 | $-1,169 |
| EPS Basic Total Ops | -0.03 | -0.10 | -0.08 | -0.11 | -0.11 |
| EPS Basic Continuous Ops | -0.04 | -0.10 | -0.08 | -0.11 | -0.11 |
| EPS Diluted Total Ops | -0.03 | -0.10 | -0.08 | -0.11 | -0.11 |
| EPS Diluted Continuous Ops | -0.04 | -0.10 | -0.08 | -0.11 | -0.11 |
| EBITDA(a) | $-624 | $-1,263 | $-1,063 | $-1,831 | $-1,209 |